Doximity (NYSE:DOCS) Stock: Insider Kira Scherer Wampler Sells 2,000 Shares

November 5, 2026 by InsiderTrades.com

Key Points

Director Kira Wampler sold 2,000 Doximity shares at an average $32.89, worth $65,780, under a pre-arranged Rule 10b5-1 plan. She retained 27,923 shares after the sale.
Doximity reported quarterly EPS of $0.29, beating the $0.16 consensus estimate; revenue was $156.62 million, up 7.3% year over year.
Analysts’ consensus rating was Hold, with an average price target of $30.73. The stock opened at $34.64, and the article reported it was up 6.3%.

Doximity, Inc. (NYSE:DOCS - Get Free Report) Director Kira Wampler sold 2,000 shares of Doximity stock in a transaction dated Monday, November 2nd. The stock was sold at an average price of $32.89, for a total value of $65,780.00. Following the sale, the director owned 27,923 shares in the company, valued at $918,387.47. This trade represents a 6.68% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Doximity is the Facebook and LinkedIn of the Medical Community

Kira Scherer Wampler also recently made the following trade(s):

On Thursday, October 1st, Kira Wampler sold 2,000 shares of Doximity stock. The shares were sold at an average price of $28.91, for a total value of $57,820.00.
On Tuesday, August 25th, Kira Wampler sold 2,000 shares of Doximity stock. The stock was sold at an average price of $24.95, for a total value of $49,900.00.

Doximity Stock Up 6.3%

DOCS opened at $34.64 on Thursday. The firm has a market cap of $6.17 billion, a price-to-earnings ratio of 40.75, a price-to-earnings-growth ratio of 25.50 and a beta of 1.29. Doximity, Inc. has a 52 week low of $17.15 and a 52 week high of $66.11. The business's 50 day moving average is $28.78 and its two-hundred day moving average is $25.59.

Doximity is an Overlooked Medical Ecosystem AI Play

Doximity (NYSE:DOCS - Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.29 earnings per share for the quarter, beating the consensus estimate of $0.16 by $0.13. The business had revenue of $156.62 million during the quarter. Doximity had a return on equity of 18.06% and a net margin of 25.48%. Doximity's revenue was up 7.3% compared to the same quarter last year. During the same period in the previous year, the company posted $0.36 earnings per share. Equities analysts expect that Doximity, Inc. will post 0.74 EPS for the current fiscal year.

Institutional Investors Weigh In On Doximity

Several hedge funds have recently modified their holdings of the stock. Mirae Asset Global Investments Co. Ltd. purchased a new position in Doximity in the 3rd quarter valued at $45,000. Versant Capital Management Inc raised its position in Doximity by 1,176.9% during the 3rd quarter. Versant Capital Management Inc now owns 1,826 shares of the company's stock worth $52,000 after buying an additional 1,683 shares during the last quarter. Nisa Investment Advisors LLC raised its position in Doximity by 59.9% during the 3rd quarter. Nisa Investment Advisors LLC now owns 1,855 shares of the company's stock worth $53,000 after buying an additional 695 shares during the last quarter. Fortitude Family Office LLC raised its position in Doximity by 31,271.4% during the 3rd quarter. Fortitude Family Office LLC now owns 2,196 shares of the company's stock worth $62,000 after buying an additional 2,189 shares during the last quarter. Finally, Parallel Advisors LLC lifted its stake in shares of Doximity by 111.0% in the 1st quarter. Parallel Advisors LLC now owns 2,560 shares of the company's stock worth $60,000 after acquiring an additional 1,347 shares during the period. 87.19% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Doximity Stock is an Interesting Healthcare Play

DOCS has been the topic of several research reports. Needham & Company LLC reissued a "buy" rating and set a $41.00 price objective on shares of Doximity in a research report on Friday, August 7th. Wolfe Research raised shares of Doximity to an "outperform" rating in a report on Thursday, August 13th. Weiss Ratings upgraded shares of Doximity from a "hold (c-)" rating to a "hold (c)" rating in a research note on Tuesday, October 6th. Zacks Research raised Doximity from a "strong sell" rating to a "hold" rating in a report on Monday, July 13th. Finally, BMO Capital Markets restated a "market perform" rating and issued a $30.00 price target on shares of Doximity in a research report on Friday, August 7th. Eight equities research analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $30.73.

View Our Latest Analysis on DOCS

Doximity News Roundup

Here are the key news stories impacting Doximity this week:

Positive Sentiment: Valuation commentary points to potential upside: one article says a model sees about 53% upside, and another describes Doximity as roughly 3% undervalued following its DoseCheck and UpToDate rollout. These are model-based assessments, not guarantees or new company guidance. Earnings To Watch: Doximity Inc (DOCS) Q2 2027 -- GF Value Sees 53% Upside Doximity Could Be 3% Undervalued Following DoseCheck And UpToDate Rollout
Neutral Sentiment: Investors are looking ahead to Doximity’s fiscal Q2 2027 results for the quarter ended September 2026. The articles preview Wall Street estimates and key metrics but do not report results, so they provide no confirmed earnings surprise. Q2 Performance and Wall Street Estimates
Negative Sentiment: Several law firms are publicizing a pending securities class action and a November 16, 2026 lead-plaintiff deadline. The complaint alleges Doximity overstated the Newsfeed product’s contribution to revenue growth and its competitive position; these are allegations, not established findings. Litigation can add uncertainty and reputational risk. DOCS Securities Class Action Deadline Alert

About Doximity

(Get Free Report)

Doximity, Inc operates a digital platform designed for medical professionals in the United States. Its network connects physicians, nurse practitioners, physician assistants, pharmacists and other healthcare professionals, providing tools for professional communication, collaboration and career development.

The company offers services including secure messaging, telehealth, digital faxing, physician scheduling and professional networking. Doximity also provides medical news and educational content, as well as recruiting and job-search resources for healthcare professionals.

Doximity generates additional revenue through digital marketing and engagement solutions for pharmaceutical companies, healthcare organizations and health systems.